# Provider Clinical Summary (PROVIDER-ONLY)

_Decision-support summary. Not a diagnosis, treatment recommendation, or dosing guidance._

**Patient:** Thomas Court (TEST-THOMAS-COURT)
**Status:** active · **Risk level:** —
**Latest assessment:** 2025-06-06T00:00:00+00:00 · **Last follow-up:** —

## Clinical snapshot
- Primary phenotype: mitochondrial_dysfunction
- Secondary phenotype: neuroinflammation
- Recovery stage (derived): intake_only — No follow-up outcomes recorded yet.
- Confidence: 54 (moderate)
- Top contributors: Fatigue, Post-exertional malaise, Unrefreshing sleep, Exercise intolerance, Muscle weakness

## Co-infection pattern scores
- bartonella: 0
- babesia: 21
- ebv: 10
- mold_cirs: 13
- mcas: 7

## Lab system scores
- inflammatory: 0
- immune: 0
- mitochondrial: 0
- hormonal: 0
- metabolic: 0
- nutritional: 0
- detoxification: 0
- neuroinflammatory: 36
- connective_tissue: 8
- Abnormal: Citrinin (DHC) (high), Ochratoxin A (OTA) (high), Homocysteine (high), MCH (high), B. burgdorferi C6 peptide IgG (high), B. burgdorferi VlsE1 IgG (high), Streptococcal A IgG (high), Herpes simplex virus 1 (HSV-1) IgG (high), Mycoplasma pneumoniae IgG (high), Parvovirus B19 VLP VP1/Vp2 Co Capsid IgG (high), B. burgdorferi p34 (OspB) IgG (high), B. burgdorferi p39 (BmpA) IgG (high), B. burgdorferi p58 IgG (high), B. burgdorferi crude extract B31 IgG (high), B. bavariensis DbpA IgM (high), B. spielmanii DbpA IgG (high), Bartonella henselae 17 kDa IgG (high), Epstein-Barr Virus VCA gp125 IgG (high), Parvovirus B19 VLP VP2 IgG (high)
- Missing: 47 marker(s)

## Provider review
- Status: not started

_Generated decision-support summary — physician review required. Source documents remain the source of truth._